ACTU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Actuate Therapeutics Inc (ACTU) is not a good buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or trends to support an immediate buy decision.
The technical indicators for ACTU are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 26.03, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 2.963 and 2.548, with resistance levels at 4.308 and 4.723. The stock's recent price trend shows a 4.92% increase in the regular market but a 2.48% drop post-market, indicating volatility without a clear upward trend.
NULL identified. No recent news or significant trading trends from hedge funds or insiders. No AI Stock Picker or SwingMax signals.
The stock's technical indicators are bearish, and there is no recent congress trading data or analyst upgrades to support a buy decision.
In Q3 2025, Actuate Therapeutics Inc reported no revenue growth (0% YoY), a net income drop to -$5,407,470 (-9.44% YoY), and a decline in EPS to -0.25 (-19.35% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance.
No analyst rating or price target changes are available for ACTU.
